STEGANZA

Class [005]
Human pharmaceutical preparations for the prevention and treatment of auto-immune diseases, cardiovascular diseases including pulmonary hypertension, pulmonary arterial hypertension, respiratory diseases including treatments of allergies and allergic responses; human pharmaceutical preparations for the prevention and treatment of gastro-intestinal diseases, oncologic diseases, ophthalmic diseases; human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; human pharmaceutical preparations for the prevention and treatment of central nervous systems diseases, namely neurological diseases, namely Alzheimer's, Huntington's disease, and cerebral palsy; human pharmaceutical preparations for the prevention and treatment of central nervous systems diseases, namely human pharmaceutical preparations for the prevention and treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; human pharmaceutical preparations for the prevention and treatment of central nervous systems diseases, namely anxiolytic medications; human pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; anti-virals, including for the prevention and treatment of HIV, anti-inflammatories, anti-infectives, and human vaccines; human pharmaceutical preparations for the relief of pain